Position in DHR
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$406,484
+$387,714 QoQ
Shares Held
2,134
+2055.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
#1,474
of 2,098 holders
Holding Since
Sep 2023
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DHR Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026E Fund Management (Hong Kong) Co., Ltd. holds $1,108,691 across 7 Diagnostics & Research names. DHR ranks #2 (36.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
844 | $423,147 | |
| 2 | DHR |
Danaher Corp /De/
This page
|
2,134 | $406,484 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
451 | $237,424 | |
| 4 | A |
Agilent Technologies, Inc.
|
102 | $13,548 | |
| 5 | WAT |
Waters Corp /De/
|
34 | $12,751 | |
| 6 | MTD |
Mettler Toledo International Inc/
|
8 | $10,220 | |
| 7 | RVTY |
Revvity, Inc.
|
46 | $5,117 |
All Filings in DHR
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $406,484 | 2,134 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $18,770 | 99 | Shares | Sole | 2026-04-08 | |
| 2025-12-31 | $8,012 | 35 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $793 | 4 | Shares | Sole | 2025-10-23 | |
| 2024-12-31 | $138,418 | 603 | Shares | Sole | 2025-01-22 | |
| 2024-09-30 | $179,322 | 645 | Shares | Sole | 2024-10-28 | |
| 2024-06-30 | $103,937 | 416 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $110,875 | 444 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $86,289 | 373 | Shares | Sole | 2024-01-05 | |
| 2023-09-30 | $52,597 | 212 | Shares | Sole | 2023-10-12 | |
| No filing history on record for this holder in this stock. | ||||||